L2 Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
L2 Asset Management's MDT Position: Q2 2026 in Review
L2 Asset Management increased its Medtronic (MDT) stake by 3.3% in Q2 2026, buying an estimated $19.1K and bringing the position to 7,340 shares worth $574K. The position accounts for 0.06% of the portfolio, ranked #237.
L2 Asset Management first reported a position in MDT in Q2 2023 and has held it in 13 quarters since. The position peaked at $3M in Q2 2023. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- L2 Asset Management held 7,340 shares of Medtronic worth $574K as of Q2 2026.
- L2 Asset Management bought 237 Medtronic shares in Q2 2026, an estimated $19.1K.
- Medtronic made up 0.06% of L2 Asset Management's portfolio in Q2 2026, its #237 holding.
- L2 Asset Management first reported a position in Medtronic in Q2 2023 and has held it in 13 quarters since.
- L2 Asset Management's Medtronic position peaked at $3M in Q2 2023.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.